Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model.
- DOI
- 10.1016/j.parkreldis.2022.105229
- Published
- 2022-11-28
- Container
- Parkinsonism Relat Disord
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.parkreldis.2022.105229,
title = {Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model.},
author = {La Vitola P and Artioli L and Cerovic M and Poletto C and Dacomo L and Leva S and Balducci C and Forloni G.},
year = {2023},
journal = {Parkinsonism Relat Disord},
doi = {10.1016/j.parkreldis.2022.105229},
url = {https://doi.org/10.1016/j.parkreldis.2022.105229}
}RIS
TY - JOUR TI - Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model. AU - La Vitola P AU - Artioli L AU - Cerovic M AU - Poletto C AU - Dacomo L AU - Leva S AU - Balducci C AU - Forloni G. PY - 2023 JO - Parkinsonism Relat Disord DO - 10.1016/j.parkreldis.2022.105229 UR - https://doi.org/10.1016/j.parkreldis.2022.105229 ER -
APA
P, L. V., L, A., M, C., C, P., L, D., S, L., C, B., & G., F. (2023). Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model.. Parkinsonism Relat Disord. https://doi.org/10.1016/j.parkreldis.2022.105229
Source records
- europe-pmc · retrieved 2026-09-27T06:02:00.166Z